These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35658529)

  • 61. Design, expression, and immunogenicity of a soluble HIV trimeric envelope fragment adopting a prefusion gp41 configuration.
    Qiao ZS; Kim M; Reinhold B; Montefiori D; Wang JH; Reinherz EL
    J Biol Chem; 2005 Jun; 280(24):23138-46. PubMed ID: 15833740
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors.
    Pacheco B; Alsahafi N; Debbeche O; Prévost J; Ding S; Chapleau JP; Herschhorn A; Madani N; Princiotto A; Melillo B; Gu C; Zeng X; Mao Y; Smith AB; Sodroski J; Finzi A
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28003492
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer.
    Liu Y; Pan J; Cai Y; Grigorieff N; Harrison SC; Chen B
    J Virol; 2017 May; 91(10):. PubMed ID: 28250125
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Monoclonal Antibody 2C6 Targets a Cross-Clade Conformational Epitope in gp41 with Highly Active Antibody-Dependent Cell Cytotoxicity.
    Sojar H; Baron S; Sullivan JT; Garrett M; van Haaren MM; Hoffman J; Overbaugh J; Doranz BJ; Hicar MD
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31217246
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Targeting antibody responses to the membrane proximal external region of the envelope glycoprotein of human immunodeficiency virus.
    Kamdem Toukam D; Tenbusch M; Stang A; Temchura V; Storcksdieck Genannt Bonsmann M; Grewe B; Koch S; Meyerhans A; Nchinda G; Kaptue L; Uberla K
    PLoS One; 2012; 7(5):e38068. PubMed ID: 22666448
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Allosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivity.
    Drummer HE; Hill MK; Maerz AL; Wood S; Ramsland PA; Mak J; Poumbourios P
    PLoS Pathog; 2013; 9(4):e1003218. PubMed ID: 23592978
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41.
    Blish CA; Nguyen MA; Overbaugh J
    PLoS Med; 2008 Jan; 5(1):e9. PubMed ID: 18177204
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein.
    Tong T; D'Addabbo A; Xu J; Chawla H; Nguyen A; Ochoa P; Crispin M; Binley JM
    PLoS Pathog; 2023 Aug; 19(8):e1011452. PubMed ID: 37549185
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of the contribution of the transmembrane region to the ectodomain conformation of the human immunodeficiency virus (HIV-1) envelope glycoprotein.
    Nguyen HT; Madani N; Ding H; Elder E; Princiotto A; Gu C; Darby P; Alin J; Herschhorn A; Kappes JC; Mao Y; Sodroski JG
    Virol J; 2017 Feb; 14(1):33. PubMed ID: 28209172
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transplanting supersites of HIV-1 vulnerability.
    Zhou T; Zhu J; Yang Y; Gorman J; Ofek G; Srivatsan S; Druz A; Lees CR; Lu G; Soto C; Stuckey J; Burton DR; Koff WC; Connors M; Kwong PD
    PLoS One; 2014; 9(7):e99881. PubMed ID: 24992528
    [TBL] [Abstract][Full Text] [Related]  

  • 71. N-terminal substitutions in HIV-1 gp41 reduce the expression of non-trimeric envelope glycoproteins on the virus.
    Dey AK; David KB; Ray N; Ketas TJ; Klasse PJ; Doms RW; Moore JP
    Virology; 2008 Mar; 372(1):187-200. PubMed ID: 18031785
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein.
    Klasse PJ; Depetris RS; Pejchal R; Julien JP; Khayat R; Lee JH; Marozsan AJ; Cupo A; Cocco N; Korzun J; Yasmeen A; Ward AB; Wilson IA; Sanders RW; Moore JP
    J Virol; 2013 Sep; 87(17):9873-85. PubMed ID: 23824824
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The lipid membrane of HIV-1 stabilizes the viral envelope glycoproteins and modulates their sensitivity to antibody neutralization.
    Salimi H; Johnson J; Flores MG; Zhang MS; O'Malley Y; Houtman JC; Schlievert PM; Haim H
    J Biol Chem; 2020 Jan; 295(2):348-362. PubMed ID: 31757809
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted viruses.
    Kraft Z; Strouss K; Sutton WF; Cleveland B; Tso FY; Polacino P; Overbaugh J; Hu SL; Stamatatos L
    J Virol; 2008 Jun; 82(12):5912-21. PubMed ID: 18400850
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies.
    Kim S; Filsinger Interrante MV; Kim PS
    J Virol; 2023 Jan; 97(1):e0164722. PubMed ID: 36541800
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification of HIV gp41-specific antibodies that mediate killing of infected cells.
    Williams KL; Stumpf M; Naiman NE; Ding S; Garrett M; Gobillot T; Vézina D; Dusenbury K; Ramadoss NS; Basom R; Kim PS; Finzi A; Overbaugh J
    PLoS Pathog; 2019 Feb; 15(2):e1007572. PubMed ID: 30779811
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Induction of Identical IgG HIV-1 Envelope Epitope Recognition Patterns After Initial HIVIS-DNA/MVA-CMDR Immunization and a Late MVA-CMDR Boost.
    Joachim A; Ahmed MIM; Pollakis G; Rogers L; Hoffmann VS; Munseri P; Aboud S; Lyamuya EF; Bakari M; Robb ML; Wahren B; Sandstrom E; Nilsson C; Biberfeld G; Geldmacher C; Held K
    Front Immunol; 2020; 11():719. PubMed ID: 32411138
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mutations That Increase the Stability of the Postfusion gp41 Conformation of the HIV-1 Envelope Glycoprotein Are Selected by both an X4 and R5 HIV-1 Virus To Escape Fusion Inhibitors Corresponding to Heptad Repeat 1 of gp41, but the gp120 Adaptive Mutations Differ between the Two Viruses.
    Zhuang M; Vassell R; Yuan C; Keller PW; Ling H; Wang W; Weiss CD
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894471
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antibody Recognition of CD4-Induced Open HIV-1 Env Trimers.
    Yang Z; Dam KA; Gershoni JM; Zolla-Pazner S; Bjorkman PJ
    J Virol; 2022 Dec; 96(24):e0108222. PubMed ID: 36448805
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Topological analysis of the gp41 MPER on lipid bilayers relevant to the metastable HIV-1 envelope prefusion state.
    Wang Y; Kaur P; Sun ZJ; Elbahnasawy MA; Hayati Z; Qiao ZS; Bui NN; Chile C; Nasr ML; Wagner G; Wang JH; Song L; Reinherz EL; Kim M
    Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22556-22566. PubMed ID: 31624123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.